NewsBenzingaHC Wainwright & Co. Reiterates Buy on Tango Therapeutics, Maintains $68 Price Target HC Wainwright & Co. Reiterates Buy on Tango Therapeutics, Maintains $68 Price Target Benzinga 2026.10.29 10:22 (GMT+0) Open on Benzinga Other news Needham Maintains Buy on eBay, Raises Price Target to $140 Needham Maintains Buy on Tenable Holdings, Raises Price Target to $55 Laureate Education Affirms FY2026 Adj EPS Guidance of $2.04-$2.10 vs $2.11 Est; Affirms FY2026 Sales Guidance of $1.920B-$1.930B vs $1.922B Est Catalyst Bancorp Q3 EPS $0.27 Up From $0.13 YoY, Sales $5.810M Up From $2.765M YoY Iovance Biotherapeutics Announced Updated Results From Cohorts 1 And 2 Of Its Phase 2 IOV-LUN-202 Trial; 24.6% Objective Response Rate In 69 Patients With Non-Squamous mNSCLC, Consistent With Previously Reported Results These Analysts Increase Their Forecasts On VF After Strong Q2 Results
Laureate Education Affirms FY2026 Adj EPS Guidance of $2.04-$2.10 vs $2.11 Est; Affirms FY2026 Sales Guidance of $1.920B-$1.930B vs $1.922B Est
Iovance Biotherapeutics Announced Updated Results From Cohorts 1 And 2 Of Its Phase 2 IOV-LUN-202 Trial; 24.6% Objective Response Rate In 69 Patients With Non-Squamous mNSCLC, Consistent With Previously Reported Results
